TaraCMitchellMD

Hematologic Oncology, Melanoma

Associate Professor, Medicine, Perelman School of Medicine

Dr. Mitchell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd
South Pavilion, 10th Floor
Philadelphia, PA 19104
Phone+1 215-615-5858

Fax+1 215-662-4646

Dr. Tara Mitchell is an oncologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. She received her medical degree from NYU Grossman School of Medicine and has been in practice 13 years. She specializes in hematologic oncology and melanoma and is experienced in mohs micrographic surgery, melanoma and cutaneous malignancies, combined modality therapy, drug interactions, and immunologic adjuvants.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

Journal Articles

Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response
Xiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor Therapy
Tara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA
Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic Melanoma
M T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology

Penn Medicine’s Tara Miller Melanoma Center Is a Trailblazer for Skin Cancer TreatmentJune 2nd, 2022
Penn Medicine and Wistar Secure $11.7 Million SPORE Grant for Three Melanoma Research ProjectsSeptember 22nd, 2021
A Single Dose of a PD-1 Inhibitor Before Surgery Predicts Outcomes in Melanoma PatientsFebruary 25th, 2019
Join now to see all